-5%
Highnoon Labs
Genthro 500mg Tablets 6s
20 Tablets
Rated 4.5 out of 5 (49)
Rs. 1,275Rs. 1,340
In Stock
Pfizer
Ibandro Tablets 150mg 1s
Rated 4.5 out of 5 (44)SKU HP-10245
A tablet containing Ibandronic Acid, indicated for Osteoporosis.
Rs. 2,535
60 Capsules
In StockSet your city for an exact delivery date
In stock at selected branches
Quantity
Ibandro Tablets 150mg 1s quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 2,535
What it is used for: Osteoporosis.
Indications as listed by the manufacturer: Ibandronic Acid is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
How it works: The action of Ibandronate on bone tissue is based on its affinity for hydroxyapatite, part of the mineral matrix of bone. Ibandronate inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass.
Active ingredient: Ibandronic Acid.
Reported side effects: Vascular Disorders : Hnoisnetrepy , Gastrointestinal Disorders : Dyspepsia , Nausea , Diarrhea , Constipation , Abdominal Pain , Musculoskeletal and Connective Tissue Disorders : Arthralgia , Back Pain, Pain in Extremity , Localized Osteoarthritis , Myalgia , Muscle Cramp , Nervous System Disorders : Headache , Dizziness , General Disorders and Administration Site Conditions : Influenza-like Illness , Skin and Subcutaneous Tissue Disorders : Rash , Psychiatric Disorders : Insomnia.
Known drug interactions: Calcium Supplements/Antacids : : Products containing calcium and other multivalent cations (such as aluminum, magnesium, iron) , Aspirin, NSAIDs, and bisphosphonates
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Adults : Treatment of post-menopausal osteoporosis to reduce risk of fractures : Adults : 150mg once a month. Children : Not Recommended. Always consult to your doctor or pharmacist for dose adjustments.
Active ingredient: Ibandronic Acid. Labelled strength: 150mg.
- Known hypersensitivity to Ibandronic Acid or to any of its excipients, Hypocalcemia, Inability to stand or sit upright for at least 60 minutes.
- Treat hypocalcemia and other disturbances of bone and mineral metabolism before starting Ibandronic Acid therapy. Adequate intake of calcium and vitamin D is important in all patients to prevent hypocalcemia.
- Severe and occasionally incapacitating bone, joint, and/or muscle pain has been reported in patients taking Ibandronic Acid and other bisphosphonates. The time to onset of symptoms varied from one day to several months after starting the drug. Most patients had relief of symptoms after stopping. A subset had recurrence of symptoms when rechallenged with the same drug or another bisphosphonate. Consider discontinuing use if severe symptoms develop.
- Osteonecrosis, primarily in the jaw, has been reported in patients treated with bisphosphonates. Most cases have been in cancer patients undergoing dental procedures, but some have occurred in patients with postmenopausal osteoporosis or other diagnoses. Known risk factors for osteonecrosis include a diagnosis of cancer, concomitant therapies (e.g., chemotherapy, radiotherapy, corticosteroids), and co-morbid disorders (e.g., anemia, coagulopathy, infection, pre-existing dental disease). Most reported cases have been in patients treated with bisphosphonates intravenously but some have been in patients treated orally. For patients who develop osteonecrosis of the jaw (ONJ) while on bisphosphonate therapy, dental surgery may exacerbate the condition.
- Ibandronic Acid like other bisphosphonates administered orally, may cause upper gastrointestinal disorders such as dysphagia, esophagitis, and esophageal or gastric ulcer. Advise patients to comply with the dosing instructions to minimize the risk of these effects. Discontinue use if new or worsening symptoms develop.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Ibandro Pharmaceuticals (Pvt) Ltd.. Country of origin: Turkey.
4.5
Rated 4.5 out of 544 verified ratings
- 5★75%
- 4★25%
- 3★0%
- 2★0%
- 1★0%
- Sana MalikVerified Purchase4 Aug 2026Rated 4.0 out of 5
Product is fine and authentic. Delivery took a day longer than the slot I picked.
- Imran Q.Verified Purchase28 Jul 2026Rated 5.0 out of 5
Good value for the pack size. I compared prices across three sites before ordering.
- Komal J.Verified Purchase17 Jul 2026Rated 5.0 out of 5
Works as expected. Took about three weeks to notice a difference, which the product page had already told me to expect.
- Zainab H.Verified Purchase11 Jul 2026Rated 5.0 out of 5
Works as expected. Took about three weeks to notice a difference, which the product page had already told me to expect.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Osteoporosis.
Indications as listed by the manufacturer: Ibandronic Acid is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
How it works: The action of Ibandronate on bone tissue is based on its affinity for hydroxyapatite, part of the mineral matrix of bone. Ibandronate inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass.
Active ingredient: Ibandronic Acid.
Reported side effects: Vascular Disorders : Hnoisnetrepy , Gastrointestinal Disorders : Dyspepsia , Nausea , Diarrhea , Constipation , Abdominal Pain , Musculoskeletal and Connective Tissue Disorders : Arthralgia , Back Pain, Pain in Extremity , Localized Osteoarthritis , Myalgia , Muscle Cramp , Nervous System Disorders : Headache , Dizziness , General Disorders and Administration Site Conditions : Influenza-like Illness , Skin and Subcutaneous Tissue Disorders : Rash , Psychiatric Disorders : Insomnia.
Known drug interactions: Calcium Supplements/Antacids : : Products containing calcium and other multivalent cations (such as aluminum, magnesium, iron) , Aspirin, NSAIDs, and bisphosphonates
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Adults : Treatment of post-menopausal osteoporosis to reduce risk of fractures : Adults : 150mg once a month. Children : Not Recommended. Always consult to your doctor or pharmacist for dose adjustments.
Active ingredient: Ibandronic Acid. Labelled strength: 150mg.
- Known hypersensitivity to Ibandronic Acid or to any of its excipients, Hypocalcemia, Inability to stand or sit upright for at least 60 minutes.
- Treat hypocalcemia and other disturbances of bone and mineral metabolism before starting Ibandronic Acid therapy. Adequate intake of calcium and vitamin D is important in all patients to prevent hypocalcemia.
- Severe and occasionally incapacitating bone, joint, and/or muscle pain has been reported in patients taking Ibandronic Acid and other bisphosphonates. The time to onset of symptoms varied from one day to several months after starting the drug. Most patients had relief of symptoms after stopping. A subset had recurrence of symptoms when rechallenged with the same drug or another bisphosphonate. Consider discontinuing use if severe symptoms develop.
- Osteonecrosis, primarily in the jaw, has been reported in patients treated with bisphosphonates. Most cases have been in cancer patients undergoing dental procedures, but some have occurred in patients with postmenopausal osteoporosis or other diagnoses. Known risk factors for osteonecrosis include a diagnosis of cancer, concomitant therapies (e.g., chemotherapy, radiotherapy, corticosteroids), and co-morbid disorders (e.g., anemia, coagulopathy, infection, pre-existing dental disease). Most reported cases have been in patients treated with bisphosphonates intravenously but some have been in patients treated orally. For patients who develop osteonecrosis of the jaw (ONJ) while on bisphosphonate therapy, dental surgery may exacerbate the condition.
- Ibandronic Acid like other bisphosphonates administered orally, may cause upper gastrointestinal disorders such as dysphagia, esophagitis, and esophageal or gastric ulcer. Advise patients to comply with the dosing instructions to minimize the risk of these effects. Discontinue use if new or worsening symptoms develop.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Ibandro Pharmaceuticals (Pvt) Ltd.. Country of origin: Turkey.
4.5
Rated 4.5 out of 544 verified ratings
- 5★75%
- 4★25%
- 3★0%
- 2★0%
- 1★0%
- Sana MalikVerified Purchase4 Aug 2026Rated 4.0 out of 5
Product is fine and authentic. Delivery took a day longer than the slot I picked.
- Imran Q.Verified Purchase28 Jul 2026Rated 5.0 out of 5
Good value for the pack size. I compared prices across three sites before ordering.
- Komal J.Verified Purchase17 Jul 2026Rated 5.0 out of 5
Works as expected. Took about three weeks to notice a difference, which the product page had already told me to expect.
- Zainab H.Verified Purchase11 Jul 2026Rated 5.0 out of 5
Works as expected. Took about three weeks to notice a difference, which the product page had already told me to expect.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
PfizerIbandro Tablets 150mg 1sRs. 2,535Rated 4.5 out of 5
StandpharmXiga 5mg Tablets 14sRs. 1,595Rated 4.5 out of 5
Martin DowAldactone Tablets 100mg 10sRs. 1,390Rated 4.5 out of 5
Bundle total
Rs. 5,520Rs. 5,765
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in Medicine
